Pomanda estimates the enterprise value of PHARM - TEX LIMITED at £306.8k based on a Turnover of £792.8k and 0.39x industry multiple (adjusted for size and gross margin).
pharm - tex limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of PHARM - TEX LIMITED at £0 based on an EBITDA of £-5.1k and a 3.89x industry multiple (adjusted for size and gross margin).
pharm - tex limitedEstimated Valuation
£7.1m
Pomanda estimates the enterprise value of PHARM - TEX LIMITED at £7.1m based on Net Assets of £3.7m and 1.94x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharm - Tex LimitedOverview
Pharm - Tex Limited is a live company located in london, W1T 6QR with a Companies House number of 02325397. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in December 1988, it's largest shareholder is
nalin lalji shah
with a 80% stake. Pharm - Tex Limited is a mature,
small sized company, Pomanda has estimated its turnover at
£792.8k with
unknown
growth in recent years.
Pomanda's financial health check has awarded Pharm - Tex Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 3 areas for improvement. Company Health Check FAQs
Health Rating1out of 5
0 Strong
3 Regular
3 Weak
Size
annual sales of £792.8k, make it smaller than the average company (£19.4m)
£792.8k - Pharm - Tex Limited
£19.4m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Pharm - Tex Limited
- - Industry AVG
Production
with a gross margin of 29.6%, this company has a comparable cost of product (29.6%)
29.6% - Pharm - Tex Limited
29.6% - Industry AVG
Profitability
an operating margin of -0.6% make it less profitable than the average company (3.2%)
-0.6% - Pharm - Tex Limited
3.2% - Industry AVG
Employees
with 2 employees, this is below the industry average (54)
2 - Pharm - Tex Limited
54 - Industry AVG
Pay Structure
on an average salary of £52.9k, the company has an equivalent pay structure (£52.9k)
£52.9k - Pharm - Tex Limited
£52.9k - Industry AVG
Efficiency
resulting in sales per employee of £396.4k, this is equally as efficient (£396.4k)
£396.4k - Pharm - Tex Limited
£396.4k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Pharm - Tex Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Pharm - Tex Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Pharm - Tex Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pharm - Tex Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Pharm - Tex Limited
- - Industry AVG
PHARM - TEX LIMITED financials
EXPORT
Pharm - Tex Limited's latest turnover from June 2024 is estimated at £792.8 thousand and the company has net assets of £3.7 million. According to their latest financial statements, Pharm - Tex Limited has 2 employees and maintains cash reserves of £2.2 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jun 2024
Jun 2023
Jun 2022
Jun 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Turnover
792,752
816,796
770,007
1,410,577
1,407,342
5,756,572
9,437,882
13,569,547
12,382,650
11,163,688
11,333,264
14,226,823
Other Income Or Grants
Cost Of Sales
558,238
572,397
538,886
1,007,030
986,942
3,961,672
6,821,348
10,789,132
10,325,626
9,159,936
9,520,321
12,020,455
Gross Profit
234,514
244,399
231,122
403,546
420,400
1,794,900
2,616,534
2,780,415
2,057,024
2,003,752
1,812,943
2,206,368
Admin Expenses
239,632
263,261
117,259
-8,322
280,089
9,817,386
-208,349
-1,520,948
628,141
1,408,001
1,393,882
1,242,370
1,768,639
1,601,079
1,448,988
Operating Profit
-5,118
-18,862
113,863
8,322
123,457
-9,396,986
208,349
1,520,948
1,166,759
1,208,533
1,386,533
814,654
235,113
211,864
757,380
Interest Payable
321
4,377
4,919
5,741
6,631
7,870
9,182
6,955
Interest Receivable
118
112
14
6,585
Pre-Tax Profit
-5,000
-18,750
113,877
8,322
123,457
-9,396,986
208,349
1,527,213
1,399,284
1,275,215
1,478,918
1,014,256
249,675
293,414
587,328
Tax
-21,637
-1,581
-23,457
-39,586
-305,442
-216,461
-259,180
-341,243
-214,866
-56,537
-55,868
-215,216
Profit After Tax
-5,000
-18,750
92,240
6,741
100,000
-9,396,986
168,763
1,221,770
1,182,823
1,016,035
1,137,675
799,390
193,138
237,546
372,112
Dividends Paid
1,000,000
200,000
400,000
Retained Profit
-5,000
-18,750
92,240
6,741
100,000
-9,396,986
168,763
1,221,770
1,182,823
16,035
937,675
799,390
193,138
237,546
-27,888
Employee Costs
105,877
102,481
93,334
167,570
165,208
570,538
1,227,177
1,216,445
1,167,826
1,594,918
1,454,686
1,294,364
Number Of Employees
2
2
2
4
4
26
31
31
30
30
30
30
EBITDA*
-5,118
-18,862
113,863
8,322
123,457
-9,396,986
208,349
1,520,948
1,188,358
1,241,683
1,420,058
850,785
272,573
235,951
781,050
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024
Jun 2023
Jun 2022
Jun 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Tangible Assets
337,696
711,157
741,296
771,024
798,128
741,297
729,011
Intangible Assets
Investments & Other
3,500,912
3,412,378
3,203,167
8,904,515
11,446,478
11,392,516
9,699,726
9,446,986
9,278,223
685,500
484,470
482,720
476,250
186,819
186,251
186,251
Debtors (Due After 1 year)
Total Fixed Assets
3,500,912
3,412,378
3,203,167
8,904,515
11,446,478
11,392,516
9,699,726
9,446,986
9,278,223
1,023,196
1,195,627
1,224,016
1,247,274
984,947
927,548
915,262
Stock & work in progress
232,684
726,707
754,299
800,907
766,866
796,863
1,271,121
Trade Debtors
538,594
1,197,709
2,069,923
1,648,357
1,472,073
1,858,955
1,263,070
Group Debtors
172,991
177,991
196,741
106,741
100,000
100,000
9,606
26,083
20,509
17,068
5,415
7,189
4,165
Misc Debtors
1,499,349
29,815
11,953
112,215
132,428
174,655
241,421
Cash
2,240
2,240
2,240
5,268,132
4,260,805
4,435,923
3,069,040
3,700,113
3,079,992
3,426,210
misc current assets
580,646
724,215
606,247
557,011
567,655
464,267
412,390
total current assets
175,231
180,231
198,981
106,741
100,000
100,000
8,129,011
6,965,334
7,898,854
6,204,598
6,644,550
6,381,921
6,618,377
total assets
3,676,143
3,592,609
3,402,148
9,011,256
11,546,478
11,492,516
9,699,726
9,446,986
9,278,223
9,152,207
8,160,961
9,122,870
7,451,872
7,629,497
7,309,469
7,533,639
Bank overdraft
10,274
566,287
238,445
Bank loan
Trade Creditors
470,883
757,670
1,585,514
1,438,327
2,415,342
1,239,880
1,588,055
Group/Directors Accounts
25,710
108,101
113,108
257,258
457,758
other short term finances
hp & lease commitments
other current liabilities
292,482
326,185
473,028
225,027
465,910
total current liabilities
799,349
1,191,956
2,171,650
1,438,327
2,415,342
2,288,452
2,750,168
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
799,349
1,191,956
2,171,650
1,438,327
2,415,342
2,288,452
2,750,168
net assets
3,676,143
3,592,609
3,402,148
9,011,256
11,546,478
11,492,516
9,699,726
9,446,986
9,278,223
8,352,858
6,969,005
6,951,220
6,013,545
5,214,155
5,021,017
4,783,471
total shareholders funds
3,676,143
3,592,609
3,402,148
9,011,256
11,546,478
11,492,516
9,699,726
9,446,986
9,278,223
8,352,858
6,969,005
6,951,220
6,013,545
5,214,155
5,021,017
4,783,471
Jun 2024
Jun 2023
Jun 2022
Jun 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Operating Activities
Operating Profit
-5,118
-18,862
113,863
8,322
123,457
-9,396,986
208,349
1,520,948
1,166,759
1,208,533
1,386,533
814,654
235,113
211,864
757,380
Depreciation
21,599
33,150
33,525
36,131
37,460
24,087
23,670
Amortisation
Tax
-21,637
-1,581
-23,457
-39,586
-305,442
-216,461
-259,180
-341,243
-214,866
-56,537
-55,868
-215,216
Stock
-232,684
-494,023
-27,592
-46,608
34,041
-29,997
-474,258
1,271,121
Debtors
-5,000
-18,750
90,000
6,741
100,000
-2,047,549
793,942
-848,778
324,745
167,724
-430,883
532,143
1,508,656
Creditors
-470,883
-286,787
-827,844
147,187
-977,015
1,175,462
-348,175
1,588,055
Accruals and Deferred Income
-292,482
-33,703
-146,843
473,028
-225,027
-240,883
465,910
Deferred Taxes & Provisions
Cash flow from operations
-118
-112
2,226
-9,396,986
168,763
2,732,374
351,488
884,186
1,420,893
-542,861
1,627,351
-466,860
-159,978
Investing Activities
capital expenditure
337,696
590,357
-90,415
15,182
-308,189
-94,860
-36,373
-96,074
Change in Investments
88,534
209,211
-5,701,348
-2,541,963
53,962
1,692,790
252,740
168,763
8,592,723
201,030
1,750
6,470
289,431
568
186,251
cash flow from investments
-88,534
-209,211
5,701,348
2,541,963
-53,962
-1,692,790
-252,740
-168,763
-8,255,027
389,327
-92,165
8,712
-597,620
-95,428
-36,373
-282,325
Financing Activities
Bank loans
Group/Directors Accounts
-25,710
-82,391
-5,007
113,108
-257,258
-200,500
457,758
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
88,534
209,211
-5,701,348
-2,541,963
53,962
1,692,790
9,649,726
-296,405
201,030
1,750
4,811,359
interest
118
112
14
6,264
-4,377
-4,919
-5,741
-6,631
-7,870
-9,182
-6,955
cash flow from financing
88,652
209,323
-5,701,334
-2,541,963
53,962
1,692,790
9,649,726
-315,851
114,262
-8,176
107,367
-6,631
-265,128
-209,682
5,262,162
cash and cash equivalents
cash
2,240
-5,268,132
1,007,327
-175,118
1,366,883
-631,073
620,121
-346,218
3,426,210
overdraft
-10,274
10,274
-566,287
327,842
238,445
change in cash
2,240
-5,257,858
997,053
-175,118
1,366,883
-631,073
1,186,408
-674,060
3,187,765
pharm - tex limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for pharm - tex limited. Get real-time insights into pharm - tex limited's credit score, group structure and payment trends.
Perform a competitor analysis for pharm - tex limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in W1T area or any other competitors across 12 key performance metrics.
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to pharm - tex limited. Currently there are 2 open charges and 1 have been satisfied in the past.
pharm - tex limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PHARM - TEX LIMITED. This can take several minutes, an email will notify you when this has completed.
pharm - tex limitedCompanies House Filings - See Documents
